Grifols S.A. American Depositary Shares (GRFS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Grifols S.A. American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$8.12
+0.25% today
Market cap
$5.6B
Overall quality
—
Kronos AI 30-day
−7.2%
0 of 8 simulated paths end higher
Grifols S.A. American Depositary Shares (GRFS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $5.6B. It trades at $8.12, up 0.25% today. 1 analysts' average target of $9.00 implies +10.8% from today's price. Kronos AI's 30-day forecast is −7.2% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $9.00 |
| Low – high | $9.00 – $9.00 |
| Analysts | 1 |
| Upside to average | +10.8% |
Kronos AI 30-day forecast
| Expected close | $7.52 (−7.2%) |
| Likely range | −9.5% … −5.9% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.